Vaccination with recombinant flagellar proteins FlgJ and FliN induce protection against Brucella abortus 544 infection in BALB/c mice

Veterinary Microbiology

Volumn 161, Issue 1-2, 2012, Pages 137-144

  Li, Xianbo ^a,b   Xu, Jie ^b,c   Xie, Yongfei ^b,d   Qiu, Yefeng ^b   Fu, Simei ^b,c   Yuan, Xitong ^b   Ke, Yuehua ^b   Yu, Shuang ^b   Du, Xinying ^b   Cui, Mingquan ^a,b   Chen, Yanfen ^b,c   Wang, Tongkun ^b   Wang, Zhoujia ^b   Yu, Yaqing ^c   Huang, Kehe ^d   Huang, Liuyu ^b   Peng, Guangneng ^a   Chen, Zeliang ^b   Wang, Yufei ^b  

^a SICHUAN AGRICULTURAL UNIVERSITY   (China)

^b BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

^c JILIN UNIVERSITY   (China)

^d NANJING AGRICULTURAL UNIVERSITY   (China)

Author keywords

Brucella; Flagellar protein; FlgJ; FliN; Protective antigen

Indexed keywords

BRUCELLA VACCINE; FLGJ PROTEIN; FLIN PROTEIN; GAMMA INTERFERON; IMMUNOGLOBULIN G; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ARTICLE; BRUCELLA ABORTUS; BRUCELLOSIS; CELLULAR IMMUNITY; CYTOKINE PRODUCTION; DRUG RESPONSE; ENZYME LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; FEMALE; HUMORAL IMMUNITY; IMMUNOGENICITY; IN VITRO STUDY; MOUSE; NONHUMAN; SPLEEN CELL; T LYMPHOCYTE;

ANIMALS; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; BRUCELLA ABORTUS; BRUCELLA VACCINE; BRUCELLOSIS; FEMALE; IMMUNITY, HUMORAL; MICE; MICE, INBRED BALB C; RECOMBINANT PROTEINS; TIME FACTORS; VACCINATION; VACCINES, SUBUNIT;

BACTERIA (MICROORGANISMS); BRUCELLA; BRUCELLA MELITENSIS BIOVAR ABORTUS; ESCHERICHIA COLI; MUS;

EID: 84869871229     PISSN: 03781135     EISSN: 18732542     Source Type: Journal    
DOI: 10.1016/j.vetmic.2012.07.016     Document Type: Article

References (27)

1. Atluri V.L., Xavier M.N., den Hartigh A.B., de Jong M.F., Tsolis R.M. Interactions of the human pathogenic Brucella species with their hosts. Annu. Rev. Microbiol. 2011, 65:523-541.
2. Busso D., Delagoutte-Busso B., Moras D. Construction of a set Gateway-based destination vectors for high-throughput cloning and expression screening in Escherichia coli. Anal. Biochem. 2005, 343:313-321.
3. Delpino M.V., Estein S.M., Fossati C.A., Baldi P.C., Cassataro J. Vaccination with Brucella recombinant DnaK and SurA proteins induces protection against Brucella abortus infection in BALB/c mice. Vaccine 2007, 25:6721-6729.
4. DelVecchio V.G., Kapatral V., Elzer P., Patra G., Mujer C.V. The genome of Brucella melitensis. Vet. Microbiol. 2002, 90:587-592.
5. DelVecchio V.G., Kapatral V., Redkar R.J., Patra G., Mujer C., Los T., Ivanova N., Anderson I., Bhattacharyya A., Lykidis A., Reznik G., Jablonski L., Larsen N., D'Souza M., Bernal A., Mazur M., Goltsman E., Selkov E., Elzer P.H., Hagius S., O'Callaghan D., Letesson J.J., Haselkorn R., Kyrpides N., Overbeek R. The genome sequence of the facultative intracellular pathogen Brucella melitensis. Proc. Natl. Acad. Sci. U.S.A. 2002, 99:443-448.
6. Eze M.O., Yuan L., Crawford R.M., Paranavitana C.M., Hadfield T.L., Bhattacharjee A.K., Warren R.L., Hoover D.L. Effects of opsonization and gamma interferon on growth of Brucella melitensis 16M in mouse peritoneal macrophages in vitro. Infect. Immun. 2000, 68:257-263.
7. Fernandes D.M., Baldwin C.L. Interleukin-10 downregulates protective immunity to Brucella abortus. Infect. Immun. 1995, 63:1130-1133.
8. Fretin D., Fauconnier A., Kohler S., Halling S., Leonard S., Nijskens C., Ferooz J., Lestrate P., Delrue R.M., Danese I., Vandenhaute J., Tibor A., DeBolle X., Letesson J.J. The sheathed flagellum of Brucella melitensis is involved in persistence in a murine model of infection. Cell Microbiol. 2005, 7:687-698.
9. Fu S., Xu J., Li X., Xie Y., Qiu Y., Du X., Yu S., Bai Y., Chen Y., Wang T., Wang Z., Yu Y., Peng G., Huang K., Huang L., Wang Y., Chen Z. Immunization of mice with recombinant protein CobB or AsnC confers protection against Brucella abortus infection. PLoS One 2012, 7:e29552.
10. Halling S.M. On the presence and organization of open reading frames of the nonmotile pathogen Brucella abortus similar to class II, III, and IV flagellar genes and to LcrD virulence superfamily. Microb. Comp. Genomics 1998, 3:21-29.
11. He Y., Xiang Z. Bioinformatics analysis of Brucella vaccines and vaccine targets using VIOLIN. Immunome Res. 2010, 1(6 Suppl.):S5.
12. Josenhans C., Suerbaum S. The role of motility as a virulence factor in bacteria. Int. J. Med. Microbiol. 2002, 291:605-614.
13. Kaufmann S.H. Intracellular pathogens: living in an extreme environment. Immunol. Rev. 2011, 240:5-10.
14. Leonard S., Ferooz J., Haine V., Danese I., Fretin D., Tibor A., de Walque S., De Bolle X., Letesson J.J. FtcR is a new master regulator of the flagellar system of Brucella melitensis 16M with homologs in Rhizobiaceae. J. Bacteriol. 2007, 189:131-141.
15. Li B., Zhou L., Guo J., Wang X., Ni B., Ke Y., Zhu Z., Guo Z., Yang R. High-throughput identification of new protective antigens from a Yersinia pestis live vaccine by enzyme-linked immunospot assay. Infect. Immun. 2009, 77:4356-4361.
16. Macnab R.M. How bacteria assemble flagella. Ann. Rev. Microbiol. 2003, 57:77-100.
17. Martirosyan A., Moreno E., Gorvel J.P. An evolutionary strategy for a stealthy intracellular Brucella pathogen. Immunol. Rev. 2011, 240:211-234.
18. Oliveira S.C., Splitter G.A. Immunization of mice with recombinant L7/L12 ribosomal protein confers protection against Brucella abortus infection. Vaccine 1996, 14:959-962.
19. Oliveira S.C., Giambartolomei G.H., Cassataro J. Confronting the barriers to develop novel vaccines against brucellosis. Expert Rev. Vaccines 2011, 10:1291-1305.
20. Paulsen I.T., Seshadri R., Nelson K.E., Eisen J.A., Heidelberg J.F., Read T.D., Dodson R.J., Umayam L., Brinkac L.M., Beanan M.J., Daugherty S.C., Deboy R.T., Durkin A.S., Kolonay J.F., Madupu R., Nelson W.C., Ayodeji B., Kraul M., Shetty J., Malek J., Van Aken S.E., Riedmuller S., Tettelin H., Gill S.R., White O., Salzberg S.L., Hoover D.L., Lindler L.E., Halling S.M., Boyle S.M., Fraser C.M. The Brucella suis genome reveals fundamental similarities between animal and plant pathogens and symbionts. Proc. Natl. Acad. Sci. U.S.A. 2002, 99:13148-13153.
21. Radhakrishnan G.K., Yu Q., Harms J.S., Splitter G.A. Brucella TIR domain-containing protein mimics properties of the Toll-like receptor adaptor protein TIRAP. J. Biol. Chem. 2009, 284:9892-9898.
22. Rossetti C.A., Galindo C.L., Lawhon S.D., Garner H.R., Adams L.G. Brucella melitensis global gene expression study provides novel information on growth phase-specific gene regulation with potential insights for understanding Brucella: host initial interactions. BMC Microbiology 2009, 9:81.
23. Schurig G.G., Sriranganathan N., Corbel M.J. Brucellosis vaccines: past present and future. Vet. Microbiol. 2002, 90:479-496.
24. Spera J.M., Ugalde J.E., Mucci J., Comerci D.J., Ugalde R.A. A B lymphocyte mitogen is a Brucella abortus virulence factor required for persistent infection. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:16514-16519.
25. Svetić A., Jian Y., Lu P., Finkeiman F., Gause W. Brucella abortus induces a novel cytokine gene expression pattern characterized by elevated IL-10 and IFN-gamma in CD4+ T cells. Int. Immunol. 1993, 5:877-883.
26. Young E.J. An overview of human brucellosis. Clin. Infect. Dis. 1995, 21:283-289. quiz 290.
27. Zhan Y., Cheers C. Endogenous gamma interferon mediates resistance to Brucella abortus infection. Infect. Immun. 1993, 61:4899-4901.